How Carmat Uses Digital Twins to Assess the Anatomical Fit of Their Total Artificial Heart Device

person holding artificial heart device

About this webinar

The use of digital twins in the healthcare space is on the rise. Not only are they being used in research and development, but they are also helping to define the best, personalized treatment for individual patients.

Carmat, a pioneering medical device company, has developed a revolutionary new total artificial heart, intended to treat patients with severe heart failure. Join us in this webinar, as Carmat reveals how they use the digital twin of a patient to evaluate anatomical compatibility, ultimately leading to successful treatment outcomes.

In this webinar, you will gain insights on:

  • How Carmat’s Total Artificial Heart functions, and what kind of patients benefit from it
  • The process of virtual implantation and why it’s necessary
  • The anatomical compatibility results of Carmat’s device

Meet the speakers

Damien Barles

Medical Imaging Program Manager, Carmat

Piet Jansen

Chief Medical Officer, Carmat

Karen De Leener

Cardiovascular Market Manager, Materialise

Share on:

Share on Facebook
Share on Twitter
Share on LinkedIn
Share with Pocket

Materialise medical device software may not be available in all markets because product availability is subject to the regulatory or medical practices in individual markets. In countries where no regulatory registration is obtained of Mimics or 3-matic Medical, a research version is available. Please contact your Materialise representative if you have questions about the availability of Materialise medical device software in your area.


You might also like